The Judith Jane Mason & Harold Stannet Williams Memorial Foundation (‘the Mason Foundation’) is a charitable trust that supports medical and scientific research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Alzheimer’s disease.
The Mason Foundation was established as a result of a generous donation in 2003 from Judith Jane Mason (nee Williams). She also made a number of top-up contributions during her lifetime. The Foundation is named in honour of the benefactor and her father, Harold Stannett Williams, who Ms Mason described as
“a most intelligent, wonderful and charitable man”.
Goal of the Mason Foundation
The goal of The Mason Foundation is to achieve enduring, positive impact in the areas of ME/CFS and Alzheimer’s disease through funding medical research principally into the causes, prevention and/or management of these diseases.
On 14 August 2019, the Mason Foundation announced funding to establish the first Australian Registry and Biobank for ME/CFS. Refer to the Equity Trustees website here for further details.
The Mason Foundation - Alzheimer’s research grants
Equity Trustees and the National Foundation for Medical Research and Innovation (NFMRI) announced a new partnership in 2018 to advance research focused on Alzheimer’s disease.
Together, we will be seeking expressions of interests for projects investigating potential treatments and/or cure for Alzheimer’s Disease that align with NFMRI’s strategy and mission. Further information is provided on NFMRI's website.
2019 Alzheimer’s research applications are now closed
The Mason Foundation – ME/CFS research grants
The Mason Foundation ME/CFS research grants support research projects that focus on Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Grants will be awarded to a maximum of $120,000 per annum, for up to 3 years.
Applications open: 1 October 2019
Applications close: 5 November 2019 (Midnight AEST)
View The Mason Foundation ME/CFS - Guidelines
Download Summary Paper and Final Report